Skip to main content
Caplight Logo









Theoria Science, Inc.

Theoria Science, Inc.

Private
TokyoHealthcare & Life Scienceshttp://theoria.co.jp/

Last Round

Series A

Aug 2, 2021

Total Funding Raised

$4.57M

Company Overview

Theoria Science, Inc. is a biotechnology company that develops exosome-based diagnostic tools and therapeutic approaches for the early detection and treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

exosome researchcancer diagnosticsliquid biopsyextracellular vesicleExoScreenearly cancer detectionbiomarker discoverydrug discoveryprecision medicinenon-invasive diagnosticsbiotech R&Doncology researchdiagnostic assay

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Theoria Science, Inc. Comparables

Compare Theoria Science, Inc. with similar companies based on industry and business-model similarity.

Theoria Science, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mercy BioAnalytics
84%
Mursla Bio
80%
Exosomics S.p.A.
79%

Theoria Science, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 2, 2021
SeedSep 6, 2019

Theoria Science, Inc. Investors

Notable investors and investment history

Theoria Science, Inc. investors
InvestorRounds
Angel BridgeSeries A, Seed
SMBC Venture CapitalSeries A
SBI Investment Co., Ltd.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 2, 2021

    $4.57M round with participation from SMBC Venture Capital.

Theoria Science, Inc. Filings

Explore SEC and related filing metadata, where available.

Theoria Science, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Theoria Science, Inc.'s valuation, stock price, and market status.

Is Theoria Science, Inc. a public or private company?

Theoria Science, Inc. is a private company.

What is the current stock price of Theoria Science, Inc.?

Theoria Science, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Theoria Science, Inc. worth (valuation)?

Valuation information for Theoria Science, Inc. is not publicly available.

Can I buy Theoria Science, Inc. stock?

Theoria Science, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Theoria Science, Inc.'s last funding round?

Theoria Science, Inc.'s most recent funding round was Series A on August 2, 2021.

Who are the main investors in Theoria Science, Inc.?

Key investors in Theoria Science, Inc. include Angel Bridge.

Will Theoria Science, Inc. IPO soon?

No public IPO plans have been announced for Theoria Science, Inc..

How can I track Theoria Science, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theoria Science, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Year Founded2012
Last FundingAug 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?